Condition
Hangover
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07332429Not ApplicableNot Yet Recruiting
Efficacy and Safety of Alcovit in Reducing Blood Alcohol Concentration
NCT07060586Not ApplicableCompleted
The Effect of Sphenopalatine Ganglion Block on Headache and Vasalgia
NCT01400204CompletedPrimary
Naturalistic Study Into the Hangover Effects of MDMA
Showing all 3 trials